TGFBR2 and non-small cell lung carcinoma: Our study is in agreement with the previous studies with lung tumour-derived cell lines that both NSCLC and SCLC cell lines show either no expression or weak expression of TβRII in 65–75% cases (Hougaard et al, 1999; Osada et al, 2001).